Official Title
Asymptomatic and Pre-symptomatic Transmission of SARS-CoV-2 in a Community Congregant Setting: a Study to Understand How Infection Control Practices Can Mitigate Exposure Risks
Brief Summary

The overall aim of this study is to measure how transmission of COVID-19 occurs incommunities - including the role of super spreaders and/or identifying conditions thatmay increase transmission risk, with a focus on congregant situations. In order toidentify how presence of symptoms and behavior affects the transmissibility of the virus,the investigators will measure SARS-CoV-2 in exhaled breath of asymptomatic andsymptomatic persons using polyvinyl alcohol (PVA) test strips embedded in face masks(Face Mask Sampling- "FMS") - an innovative, non-invasive method for detection ofSARS-CoV-2 in exhaled air.

Detailed Description

Not Provided

Unknown status
COVID-19
SARS-CoV2 Infection

Device: Polyvinylalcohol strip [diagnostic]

The investigators will measure SARS-CoV-2 in exhaled breath of asymptomatic and
symptomatic persons using PVA test strips embedded in face masks (FMS) - an innovative,
non-invasive method for detection of SARS-CoV-2 in exhaled air. Utilizing this approach,
the study aims to utilize the test results extracted from the masks to identify risk
factors for SARS-CoV-2 transmission and timing of infectious period in exposed people
(pre-symptomatic, asymptomatic, and symptomatic).

Eligibility Criteria

Inclusion Criteria:

- Individuals age ≥ 18 years of any gender tested positive for SARS-CoV-2 by a
molecular reference test (PCR test or antigen test) [INDEX PATIENTS]

- Individuals age ≥ 18 years and known to be contacts of the index patients [CONTACTS]

Exclusion Criteria:

- < age 18 years old, unable to wear a face mask due to underlying condition, not able
to consent, pregnancy. In addition, signs of severe disease present at time of
enrollment (e.g. difficulty breathing, pain when breathing, tightness of chest or
developing irregular heart beat).

Eligibility Gender
All
Eligibility Age
Minimum: 18 Years ~ Maximum: N/A
Countries
United States
Locations

Anschutz Medical Campus
Aurora, Colorado, United States

University of Colorado, Boulder
Boulder, Colorado, United States

University of Colorado, Colorado Springs
Colorado Springs, Colorado, United States

Denver Health
Denver, Colorado, United States

Regis University
Denver, Colorado, United States

Colorado State University
Fort Collins, Colorado, United States

Contacts

Thomas Jaenisch, MD, PhD
720-626-1094
thomas.jaenisch@cuanschutz.edu

Colorado School of Public Health
NCT Number
Keywords
COVID-19 Transmission
SARS-CoV2 Transmission
MeSH Terms
Infections
COVID-19